Table 2.
Effects of OLIVE and SOYBEAN on Markers of Nutrition in Patients Receiving Parenteral Nutrition
| Nutrition Marker | OLIVE | SOYBEAN | OLIVE vs SOYBEAN | ||||
|---|---|---|---|---|---|---|---|
| Visit | N | Mean ± SD | N | Mean ± SD | LSGM Ratio (95 % CI) | P-value | |
| Albumin (g/L) | Baseline | 214 | 33.11 ± 5.75 | 220 | 33.23 ± 5.84 | . | |
| Day 5 | 211 | 34.02 ± 5.32 | 216 | 32.93 ± 5.15 | 1.04 (1.01, 1.07) | 0.0139 | |
| EOT/Day 14 | 82 | 35.37 ± 5.86 | 78 | 35.55 ± 5.3 | 1 (0.96, 1.05) | 0.9393 | |
| Prealbumin (mg/dL) | Baseline | 213 | 15.08 ± 4.64 | 219 | 15.15 ± 5.01 | . | |
| Day 5 | 217 | 15.66 ± 5.12 | 218 | 13.95 ± 5.05 | 1.12 (1.06, 1.19) | 0.0002 | |
| EOT/Day 14 | 210 | 17.24 ± 6.82 | 219 | 15.15 ± 6.37 | 1.16 (1.08, 1.24) | 0.0001 | |
| Prealbumin (PP) (mg/dL) | Baseline | 182 | 14.82 ± 4.58 | 188 | 14.97 ± 5.02 | . | |
| Day 5 | 184 | 15.7 ± 5.01 | 190 | 14.19 ± 5.06 | 1.12 (1.05, 1.19) | 0.0006 | |
| EOT/Day 14 | 184 | 17.38 ± 6.96 | 193 | 15.37 ± 6.43 | 1.16 (1.07, 1.25) | 0.0002 | |
| IGF-I (ug/L) | Baseline | 214 | 107.31 ± 49.61 | 220 | 110.9 ± 55.34 | . | |
| Day 5 | 211 | 125.81 ± 64.35 | 218 | 121.15 ± 61.11 | 1.04 (0.96, 1.13) | 0.3437 | |
| EOT/Day 14 | 82 | 142.9 ± 70.16 | 78 | 125.27 ± 65.22 | 1.16 (1, 1.35) | 0.045 | |
| 6-h urea nitrogen, urine (mmol/L) | Baseline | 211 | 124.02 ± 92.1 | 218 | 129.39 ± 78.47 | . | |
| Day 5 | 211 | 141.95 ± 100.85 | 216 | 151.82 ± 98.15 | 0.91 (0.8, 1.03) | 0.1271 | |
| EOT/Day 14 | 81 | 150.4 ± 100.19 | 76 | 144 ± 101.81 | 1 (0.82, 1.23) | 0.9797 | |
| 6-h 3-Methylthistidine, urine (ug/mL) | Baseline | 211 | 1.32 ± 2.61 | 217 | 1.37 ± 1.56 | . | |
| Day 5 | 212 | 1.44 ± 4.29 | 216 | 1.11 ± 0.98 | 1.02 (0.9, 1.14) | 0.7791 | |
| EOT/Day 14 | 81 | 1.98 ± 2.18 | 77 | 1.74 ± 4.4 | 1.1 (0.87, 1.38) | 0.4224 | |
Abbreviations: CI confidence interval, EOT end of therapy, IGF-I insulin-like growth factor-I, LSGM least square geometric mean, PP per protocol, SD standard deviation